Efficacy and safety of acupuncture in the treatment of pain in patients with hepatocellular carcinoma: A protocol of a randomized, single-blind, placebo-controlled clinical trial : Efficacy and safety of acupuncture in the treatment of pain in patients with hepatocellular carcinoma: A protocol of a randomized, single-blind, placebo-controlled clinical trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Pain is one of the most important clinical symptoms in patients with hepatocellular carcinoma, which seriously affects the quality of life of patients. Conventional analgesic programs can not effectively solve the pain of patients, and long-term medication accompanied by adverse reactions. There is evidence that acupuncture can relieve pain in cancer patients. Although acupuncture has been used in the treatment of cancer pain such as lung cancer, stomach cancer and liver cancer pain, and got positive feedback. acupuncture; hepatocellular carcinoma; pain; randomized controlled trial; protocol;acupuncture; hepatocellular carcinoma; pain; randomized controlled trial; protocol
Phase: Phase 1
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 26-06-2022, Last updated: 2023-06-05

ICTRP ID:

TCTR20220626001
Nil Known

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO008560803